Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer

NCT02031328 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT02031328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02031328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2014
Completion date
September 12, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma